Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A double-blind phase I trial comparing fast-acting insulin with insulin aspart and regular insulin in healthy volunteers.

Next Previous
Trial Profile

A double-blind phase I trial comparing fast-acting insulin with insulin aspart and regular insulin in healthy volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Aug 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin (Primary) ; Insulin aspart
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use

Most Recent Events

  • 10 Aug 2011 New trial record
  • 15 Jun 2011 Results will be presented at the 2nd Annual Protein Formulation Development Forum, the 71st Scientific Sessions of the American Diabetes Association and the 38th Annual Meeting of the Controlled Release Society, according to an Adocia media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top